|
| ESID : Scientific Programme | |
Untitled Document
Wednesday
October 6, 2010 |
Thursday
October 7, 2010
|
Friday
October 8, 2010
|
Saturday
October 9, 2010 |
Please click on the tabs to see programme details.
Wednesday, October 6, 2010 |
| 07.30-09.00 |
ESID BOARD MEETING (Hall: Sultan 3) |
|
Hall 1 |
Hall 2 |
Hall 3 |
Hall 4 |
Hall 5 |
Hall 6 |
| 9.00-10.30 |
Workshop Education
Group 1
HLH causes, diagnosis & treatment
Alain Fischer & Jan-Inge Henter |
Workshop Education
Group 2
Molecular diagnostics in PID: uses & abuses
Naomi Taylor & Kimberly Gilmour |
Workshop Education
Group 3
Chronic mucocutaneous candidiasis - without AIRE defect; role of innate immunity
Desa Lilic & Anne Puel |
Workshop Education Group 4
Management of patients with antibody deficiency
Helen Chapel & Gavin Spickett |
Workshop Education
Group 5
Hyper IgE syndromes: new understandings;
implications for treatment
Bodo Grimbacher & Yoshi Minegishi |
|
| 10.30-11.00 |
COFFEE BREAK |
| 11.00-12.30 |
Workshop Education
Group 6
IPEX & IPEX-like disorders: clinical features; how to treat
Eleonora Gambineri & Mary Slatter |
Workshop Education
Group 7
The use of specific antimicrobial antibodies in the diagnosis of antibody deficiency
Isıl Barlan & David Edgar |
Workshop Education
Group 8
Thymic disorders & their treatment
Georg Hollaender & Graham Davies |
Workshop Education Group 9
Management of CGD & results from HSCT
Reinhard Seger & Terry Flood |
Workshop Education
Group 10
Wiskott Aldrich Syndrome / XLT; how do we treat?
Luigi Notarangelo & Hans Ochs |
Workshop Education Group 11
Complement disorders: understanding old & new
Michael Kirschfink & Helen Chapel |
| 12.30-13.30 |
LUNCH |
| 13.30-15.00 |
Plenary Education
Session 1
HSCT for PID: why & when?
Andrew Cant
Susceptibility to viral infections: new insights
Jean-Laurent Casanova |
|
|
|
|
|
| 15.00-15.15 |
COFFEE BREAK |
| 15.15-16.45 |
Plenary Education
Session 2
Overview of neutrophil disorders: SCN, LAD, Schwachman Diamond etc
Christoph Klein
Disorders of DNA repair: recognition, treatment & outcome,including DNAPK
Andy Gennery |
|
|
|
|
|
| 16.45-17.10 |
ESID, INGID, IPOPI Opening session and the triumphs of past two years for ESID, INGID, IPOPI |
|
|
|
|
|
| 17:10-17:15 |
BAXTER Fellowship Awards
Chairman: Amos Etzioni |
|
|
|
|
|
| 17:15-18:00 |
How did our complex immune system evolve ?
Max Cooper
Chairman: Amos Etzioni |
|
|
|
|
|
| 18.00-18.45 |
Opening Ceremony |
| 19.30-23.00 |
WELCOME RECEPTION at Adile Sultan Palace |
Thursday October 7, 2010 |
| 8.00-9.00 |
Hall 1 |
Sunrise Education Session 1 |
New insights into hereditary angio-oedema |
Marco Cicardi &
Hilary Longhurst |
| 8.00-9.00 |
Hall 2 |
Sunrise Education Session 2 |
Diagnosis of PID by flow cytometry |
Jacques van Dongen |
| 8.00-9.00 |
Hall 3 |
Sunrise Education Session 3 |
Understanding B cell disorders |
Mary Ellen Conley |
| 9.00-10.30 |
Hall 1 |
Plenary Session I |
Chairs: Alain Fischer, Yıldız Camcıoğlu, |
| |
New SCID defects : Coronin 1A |
Jennifer Puck |
| |
Calcium Channel Defects |
Stefen Feske |
| |
Reticular dysgenesis |
Klaus Schwartz |
| |
Two Oral presentations |
OR1 – OR2 |
| 10.30-11.00 |
COFFEE BREAK and POSTER VIEWING |
| 11.00-12.30 |
Hall 1 |
Plenary Session II |
Chairs: Bobby Gaspar, Ismail Reisli |
| |
Gene Therapy for PID: Current status and future prospects |
Adrian Thrasher |
| |
Homologous recombination-mediated gene therapy |
Matthew Porteus |
| |
for the PIDs. |
|
| |
IPS cells and PIDs |
Luigi Notarangelo |
| |
Two Oral presentations |
OR3 – OR4 |
| 12.30-13.15 |
LUNCH and POSTER VIEWING |
| 13.15-14.45 |
Satellite Symposium 1
BAXTER
HALL 1 |
Expanding and Individualizing Immunoglobulin Treatment
Welcome and Introduction
Prof. Helen Chapel (chair)
|
Early diagnosis and treatment of patients with primary immunodeficiency are essential
Prof. Bodo Grimbacher
Update on the diagnosis rate of patients with primary immunodeficience
Consequences of late diagnosis and delayed treatment
Awareness for primary immunodeficiency |
Individualizing Immunoglobulin Replacement Therapy
Prof. Helen Chapel
Immunoglobulin trough level to maintain a minimal infectious burden is unique to the individual
Relationships between doses of replacement therapy, infection rates and immunoglobulin trough levels
Considerations for individual immunoglobulin treatment
|
Expanding intravenous immunoglobulin treatment to home therapy
Dr. Joris van Montfrans
Feasibility, safety and efficacy of IVIg home treatment
Implications for health care professionals and patients
Experience and practical considerations
|
|
| 13.15-14.45 |
Satellite Symposium 3
GRIFOLS
HALL 2 |
Key aspects for an adequate immunoglobulin therapy of primary immunodeficiencies
Chairman: C. Cunningham-Rundles |
| 13:15 |
Welcoming and Introduction |
C. Cunningham-Rundles
(New York, USA) |
| 13:25 |
IVIg in immunodeficiencies:
More than mere replacement therapy |
S. Kaveri
(Paris, France) |
| 13:45 |
Autoimmunity in Primary Immune Deficiency:
taking lessons from our patients |
C. Cunningham-Rundles |
| 13:55 |
The experience with Flebogammadif® in ITP |
A. Julia (Barcelona, Spain) |
| 14:10 |
Successful Immune globulin treatment:
indications and monitoring |
C. Cunningham-Rundles |
| 14:30 |
Discussion & closing remarks |
| 14:45 |
Conclusion |
|
| 14.45-16.15 |
Hall 1 |
Plenary Session III |
Chairs: Jean-laurent Casanova, Şebnem Kılıç |
| |
Interferon-opaties: Genetic Disorders of type I Interferon metabolism |
Yannick J Crow |
| |
Inborn errors of Interferon Immunity and susceptibility to virus infections |
Shen Ying Zhang |
| |
Two oral presentations |
OR5 –OR6 |
| 16.15-16.30 |
COFFEE BREAK and POSTER VIEWING |
| 16.30-18.00 |
Hall 1 |
Paralel Workshop I |
| |
PID Awareness and Networking |
Laszlo Marodi |
| |
|
Aydan İkincioğulları |
| 16.30-18.00 |
Hall 2 |
Paralel Workshop II |
| |
High screening methods - EUROGENEscan, |
Edvard Smith |
| |
SCID-TRECscreening, etc.. |
Jennifer Puck |
| 16.30-18.00 |
Hall 3 |
Paralel Workshop III |
| |
New advances in HSCT |
Bobby Gaspar |
| |
|
Alain Fischer |
| 18.30-20.00 |
Dinner workshop for ESID working party 1- ESID Juniors WP |
| |
Dinner workshop for ESID working party 2: Genetics WP |
| |
Dinner workshop for ESID working party 3: Registry WP |
| |
Dinner workshop for ESID working party 4: Education WP |
| |
Dinner workshop for ESID working party 5: Clinical WP |
| |
Dinner workshop for ESID working party 6: BMT/gene therapy WP |
| |
Dinner workshop for ESID working party 7: PID care in development |
| |
ESID juniors workshop
Summary of ESID juniors activities: 18.30-18.50
ESID juniors awards: 18.50-19.10
ESID juniors 'Golden mentors' awards, short career advice: 19.10-19.30
What's next for ESID juniors, brainstorming session, 19.30-20.00
'Visual reflections on PIDs'- open of the art exhibition, 20.00 |
Friday October 8, 2010 |
| 8.00-9.00 |
Hall 1 |
Sunrise Education Session 4 |
Immunotherapy with viral specific CTLs |
Bobby Gaspar |
| 8.00-9.00 |
Hall 2 |
Sunrise Education Session 5 |
Leucocyte adhesion deficiency: clinical & laboratory features |
Amos Etzioni |
| 8.00-9.00 |
Hall 3 |
Sunrise Education Session 6 |
The ESID registry: what we have learnt, what next |
Gerhard Kindle & Bodo Grimbacher |
| 9.00-10.30 |
Hall 1 |
Plenary Session IV |
Chairs: Bodo Grimbacher, Ozden Anal |
| |
CVID- from common and variable to distinct subgroups of hypogammaglobulinemia |
Klaus Warnatz |
| |
TACI signalling and the induction of Immunoglobulin class-switching |
Andrea Cerutti |
| |
Two Oral presentations |
OR7 - OR8 |
| 10.30-11.00 |
COFFEE BREAK and POSTER VIEWING |
| 11.00-12.30 |
Hall 1 |
Plenary Session V |
Chairs:Luigi Notorangelo, Günnur Deniz |
| |
Induction of Th17 responses to fungal infection |
Caetano Reis e Sousa |
| |
IL-17 and T regs connection |
Talal Chatila |
| |
Two Oral presentations |
OR9 – OR10 |
| 12.30-13.15 |
LUNCH and POSTER VIEWING |
| 13.15-14.45 |
Satellite Symposium 4
Octapharma
HALL 1 |
How can we secure plasma product supply for the PID community in a changing environment
Chair: Dr. Stephen Jolles |
| Introduction |
Stephen Jolles |
| Current and potential emerging clinical uses for IVIG: the neurologist’s view |
Richard Dodel |
| Mastering the challenges in the IVIG market: the PPTA perspective |
Charles Waller |
| Octapharma's contribution to securing availability of plasma therapies |
Kim Björnstrup |
| Discussion & Summary |
Stephen Jolles |
|
| 13.15-14.45 |
Satellite Symposium 5
CSL Behring
HALL 2 |
Bringing immunoglobulin knowledge up to date:
How should we treat today?
Chair: Prof. Jordan Orange |
| Introduction |
Jordan Orange |
| Understanding outcomes in immunodeficiencies: endpoints and targets |
Bodo Grimbacher |
| Optimizing SCIG usage: recent insights from clinical studies |
Siraj Misbah |
Scientific keynote: Fc receptors in IgG therapy |
Taco Kuijpers |
| Q& A |
Jordan Orange |
| Chair’s conclusion: Applying the lessons of today |
Jordan Orange |
|
| 14.45-16.15 |
Hall 1 |
Plenary Session VI |
Chairs: Naomi Taylor, Olcay Yeğin |
| |
Disease related to defective IFN-gamma production (MSMD) |
Laurent Abel |
| |
Treating HLH by blocking IFN-gamma |
Alain Fischer |
| |
Two oral presentations |
OR11 - OR12 |
| 16.15-18:00 |
Hall 1 |
Oral Presentations I
OR17-OR23, OR38, OR41 |
Chairs: Crina Samarghitean, Guzide Aksu |
| 16.15-18:00 |
Hall 2 |
Oral Presentations II
OR24-OR30, OR39, OR42 |
Chairs: Esther de Vries, Figen Doğu |
| 16.15-18:00 |
Hall 3 |
Oral Presentations III
OR31-OR37, OR40 |
Chairs: Laszlo Marodi, Ferah Genel |
| 18.00-22.00 |
DINNER CRUISE ON BOSPHORUS |
Saturday October 9, 2010 |
| 8.00-9.00 |
Hall 1 |
Sunrise Education Session 7 |
T cell differentiation |
Naomi Taylor
Batu Erman |
| 8.00-9.00 |
Hall 2 |
Sunrise Education Session 8 |
The laboratory diagnosis of defects of the type-1 cytokine system & innate immunity (NEMO, IRAK4, etc) |
Capucine Picard |
| 8.00-9.00 |
Hall 3 |
Sunrise Education Session 9 |
The laboratory approach to the differential diagnosis of Hyper IgM syndromes |
Anne Durandy |
| 9.00-10.30 |
Hall 1 |
Plenary Session VII |
Chairs: Elonora Gambieri, Aydan İkincioğulları |
| |
Immune dysregulation |
Mark S Anderson |
| |
IPEX and IPEX-like syndromes |
Maria Grazia Roncarolo |
| |
Two Oral presentations |
OR13 – OR14 |
| 10.30-11.00 |
COFFEE BREAK and POSTER VIEWING |
| 11.00-12.30 |
Hall 1 |
Plenary Session VIII |
Chairs: T Chatila , Işıl Barlan |
| |
The autosomal recessive forms of HyperIgE syndrome (DOCK8) |
Bodo Grimbacher |
| |
HIES and STAT3 |
Yoshi Minegishi |
| |
Two Oral presentations |
OR15 – OR16 |
| 12.30-13.30 |
LUNCH and POSTER VIEWING |
| 13.30-14.30 |
Hall 1 |
Late Breakers |
|
|
| 14.30-15.30 |
Hall 1 |
Keynote Closing Lecture
Chair: Necil Kutukculer |
Crohn’s is an immunodeficiency disease of macrophages |
Anthony Segal |
| 15.30-16.00 |
Hall 1 |
Closing Ceremony of ESID,INGID, IPOPI |
| 16.00-17.30 |
Hall 1 |
ESID General Assembly |
| 17.30-19:30 |
ESID BOARD MEETING (Hall: Sultan 3) |
| 19.30-23.00 |
GALA DINNER at Rahmi Koç Museum |
|
|
